The biochemical toxicology of
1,3-difluoroacetone, a known metabolite of the major ingredient of the
pesticide Gliftor (1,3-difluoro-2-propanol), was investigated in vivo and in vitro. Rat kidney homogenates supplemented with
coenzyme A,
ATP,
oxaloacetate, and Mg2+ converted
1,3-difluoroacetone to (-)-erythro-
fluorocitrate in vitro. Administration of
1,3-difluoroacetone (100 mg kg(-1)
body weight) to rats in vivo resulted in (-)-erythro-
fluorocitrate synthesis in the kidney, which was preceded by an elevation in
fluoride levels and followed by
citrate accumulation. Animals dosed with
1,3-difluoroacetone did not display the 2-3 hour lag phase in either (-)-erythro-
fluorocitrate synthesis or in
citrate and
fluoride accumulation characteristic of animals dosed with
1,3-difluoro-2-propanol. We demonstrate that the conversion of
1,3-difluoro-2-propanol to
1,3-difluoroacetone by an
NAD+-dependent oxidation is the rate-limiting step in the synthesis of the toxic product, (-)-erythro-
fluorocitrate from
1,3-difluoro-2-propanol. Prior administration of
4-methylpyrazole (90 mg kg(-1)
body weight) was shown to prevent the conversion of
1,3-difluoro-2-propanol (100 mg kg(-1)
body weight) to (-)-erythro-
fluorocitrate in vivo and to eliminate the
fluoride and
citrate elevations seen in 1,3-difluoro-2-propanol-intoxicated animals. However, administration of
4-methylpyrazole (90 mg kg(-1)
body weight) to rats 2 hours prior to
1,3-difluoroacetone (100 mg kg(-1)
body weight) was ineffective in preventing (-)-erythro-
fluorocitrate synthesis and did not diminish
fluoride or
citrate accumulation in vivo. We conclude that the prophylactic and antidotal properties of
4-methylpyrazole seen in animals treated with
1,3-difluoro-2-propanol derive from its capacity to inhibit the
NAD+-dependent oxidation responsible for converting
1,3-difluoro-2-propanol to
1,3-difluoroacetone in the committed step of the toxic pathway.